These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 9872599

  • 1. Plasminogen activator system modulates invasive capacity and proliferation in prostatic tumor cells.
    Festuccia C, Dolo V, Guerra F, Violini S, Muzi P, Pavan A, Bologna M.
    Clin Exp Metastasis; 1998 Aug; 16(6):513-28. PubMed ID: 9872599
    [Abstract] [Full Text] [Related]

  • 2. In vitro regulation of pericellular proteolysis in prostatic tumor cells treated with bombesin.
    Festuccia C, Guerra F, D'Ascenzo S, Giunciuglio D, Albini A, Bologna M.
    Int J Cancer; 1998 Jan 30; 75(3):418-31. PubMed ID: 9455804
    [Abstract] [Full Text] [Related]

  • 3. Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination.
    Festuccia C, Angelucci A, Gravina GL, Biordi L, Millimaggi D, Muzi P, Vicentini C, Bologna M.
    Thromb Haemost; 2005 May 30; 93(5):964-75. PubMed ID: 15886816
    [Abstract] [Full Text] [Related]

  • 4. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
    Pulukuri SM, Gondi CS, Lakka SS, Jutla A, Estes N, Gujrati M, Rao JS.
    J Biol Chem; 2005 Oct 28; 280(43):36529-40. PubMed ID: 16127174
    [Abstract] [Full Text] [Related]

  • 5. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].
    Kobayashi H.
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug 28; 48(8):623-32. PubMed ID: 8808830
    [Abstract] [Full Text] [Related]

  • 6. Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness.
    Holst-Hansen C, Johannessen B, Høyer-Hansen G, Rømer J, Ellis V, Brünner N.
    Clin Exp Metastasis; 1996 May 28; 14(3):297-307. PubMed ID: 8674284
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of plasminogen activation protects against ganglion cell loss in a mouse model of retinal damage.
    Zhang X, Chaudhry A, Chintala SK.
    Mol Vis; 2003 Jun 12; 9():238-48. PubMed ID: 12813409
    [Abstract] [Full Text] [Related]

  • 8. Activation of pro-uPA is critical for initial escape from the primary tumor and hematogenous dissemination of human carcinoma cells.
    Bekes EM, Deryugina EI, Kupriyanova TA, Zajac E, Botkjaer KA, Andreasen PA, Quigley JP.
    Neoplasia; 2011 Sep 12; 13(9):806-21. PubMed ID: 21969814
    [Abstract] [Full Text] [Related]

  • 9. Osteoblast-derived TGF-beta1 modulates matrix degrading protease expression and activity in prostate cancer cells.
    Festuccia C, Angelucci A, Gravina GL, Villanova I, Teti A, Albini A, Bologna M.
    Int J Cancer; 2000 Feb 01; 85(3):407-15. PubMed ID: 10652434
    [Abstract] [Full Text] [Related]

  • 10. Osteoblasts modulate secretion of urokinase-type plasminogen activator (uPA) and matrix metalloproteinase-9 (MMP-9) in human prostate cancer cells promoting migration and matrigel invasion.
    Festuccia C, Giunciuglio D, Guerra F, Villanova I, Angelucci A, Manduca P, Teti A, Albini A, Bologna M.
    Oncol Res; 1999 Feb 01; 11(1):17-31. PubMed ID: 10451028
    [Abstract] [Full Text] [Related]

  • 11. The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin.
    McGowen R, Biliran H, Sager R, Sheng S.
    Cancer Res; 2000 Sep 01; 60(17):4771-8. PubMed ID: 10987285
    [Abstract] [Full Text] [Related]

  • 12. Generation of cell surface-bound plasmin by cell-associated urokinase-type or secreted tissue-type plasminogen activator: a key event in melanoma cell invasiveness in vitro.
    Meissauer A, Kramer MD, Schirrmacher V, Brunner G.
    Exp Cell Res; 1992 Apr 01; 199(2):179-90. PubMed ID: 1531956
    [Abstract] [Full Text] [Related]

  • 13. Kinetics of reciprocal pro-urokinase/plasminogen activation--stimulation by a template formed by the urokinase receptor bound to poly(D-lysine).
    Petersen LC.
    Eur J Biochem; 1997 Apr 15; 245(2):316-23. PubMed ID: 9151959
    [Abstract] [Full Text] [Related]

  • 14. Pleiotrophic inhibition of pericellular urokinase-type plasminogen activator system by endogenous tumor suppressive maspin.
    Biliran H, Sheng S.
    Cancer Res; 2001 Dec 15; 61(24):8676-82. PubMed ID: 11751384
    [Abstract] [Full Text] [Related]

  • 15. Exploitation of astrocytes by glioma cells to facilitate invasiveness: a mechanism involving matrix metalloproteinase-2 and the urokinase-type plasminogen activator-plasmin cascade.
    Le DM, Besson A, Fogg DK, Choi KS, Waisman DM, Goodyer CG, Rewcastle B, Yong VW.
    J Neurosci; 2003 May 15; 23(10):4034-43. PubMed ID: 12764090
    [Abstract] [Full Text] [Related]

  • 16. Urokinase induces receptor mediated brain tumor cell migration and invasion.
    MacDonald TJ, DeClerck YA, Laug WE.
    J Neurooncol; 1998 Dec 15; 40(3):215-26. PubMed ID: 10066093
    [Abstract] [Full Text] [Related]

  • 17. Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor system.
    Yin S, Lockett J, Meng Y, Biliran H, Blouse GE, Li X, Reddy N, Zhao Z, Lin X, Anagli J, Cher ML, Sheng S.
    Cancer Res; 2006 Apr 15; 66(8):4173-81. PubMed ID: 16618739
    [Abstract] [Full Text] [Related]

  • 18. ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade.
    Baricos WH, Cortez SL, el-Dahr SS, Schnaper HW.
    Kidney Int; 1995 Apr 15; 47(4):1039-47. PubMed ID: 7540230
    [Abstract] [Full Text] [Related]

  • 19. Urokinase-mediated extracellular matrix degradation by human prostatic carcinoma cells and its inhibition by retinoic acid.
    Webber MM, Waghray A.
    Clin Cancer Res; 1995 Jul 15; 1(7):755-61. PubMed ID: 9816042
    [Abstract] [Full Text] [Related]

  • 20. Bimodal relationship between invasion of the amniotic membrane and plasminogen activator activity.
    Tsuboi R, Rifkin DB.
    Int J Cancer; 1990 Jul 15; 46(1):56-60. PubMed ID: 2142142
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.